Related Experiment Video
Updated: Feb 28, 2026
08:51
Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
9.0K
Malonyl-CoA Decarboxylase: A Spotlight on Brain Aspects
Monique Fonseca-Teixeira1, Elaine Silva Brito1, Clara Beltrao-Valente1
1Laboratório de Erros Inatos do Metabolismo, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-599, RJ, Brazil.
Brain Sciences
|February 27, 2026
Summary
Malonyl-CoA decarboxylase (MCD) is crucial for fatty acid metabolism but its brain function is unclear. Understanding MCD in the central nervous system could reveal new treatments for metabolic disorders.
Area of Science:
- Biochemistry
- Neuroscience
- Metabolic Disorders
Background:
- Malonyl-CoA decarboxylase (MCD) regulates fatty acid metabolism in peripheral tissues.
- The role and regulation of MCD in the central nervous system (CNS) are poorly understood.
- MCD deficiency causes malonic aciduria, impacting the CNS.
Purpose of the Study:
- To explore the knowns and unknowns of MCD physiology, regulation, and pathophysiology in the brain.
- To highlight gaps in understanding MCD's cellular distribution, regulatory pathways, and interaction with CPT1c in neural metabolism.
- To discuss the therapeutic potential of modulating MCD activity for metabolic disorders.
Main Methods:
- Literature review and synthesis of existing research on MCD.
- Analysis of MCD expression patterns during brain development and in response to nutritional states.
- Discussion of potential regulatory mechanisms (PPAR-α, AMPK, SIRT4) and metabolic interactions (CPT1c).
Main Results:
- MCD is expressed in various cellular compartments (mitochondria, cytosol, peroxisomes) within the brain.
- MCD expression is dynamic during development and responsive to nutritional status.
- MCD deficiency leads to neurotoxic malonic acid accumulation, but mechanisms are unclear.
Conclusions:
- Further research into MCD's brain-specific functions is critical.
- Understanding MCD regulation and interactions is key to developing targeted therapies for CNS metabolic diseases.
- MCD represents a potential therapeutic target for conditions involving altered malonyl-CoA dynamics.
Related Concept Videos
01:35Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
2.7K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.7K
01:28Overview of Fatty Acid Metabolism
37.4K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.4K
01:02Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
4.0K
Carboxylic acids, upon heating, undergo a decarboxylation reaction by releasing carbon dioxide gas. Monocarboxylic acids do not undergo decarboxylation easily. However, a silver salt of carboxylic acid reacts with bromine or iodine under high temperature to release carbon dioxide gas and forms halide with one less carbon. This reaction is called the Hunsdiecker reaction.
4.0K
01:29Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:27Protein Import into the Peroxisomes
5.5K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.5K